Protara Therapeutics Inc

Market Cap

$254M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$4.16-$1.22 (-22.68%)

Jun 5, 2026

52W High $7.5652W Low $2.78

Company Details

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, wh...

CEO

—

IPO Date

Oct 22, 2014

Website

www.protaratx.com

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$63M

EPS (Diluted)

Free Cash Flow

-$63M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q2 2026

Aug 11, 2026

PENDING

Q1 2026

May 13, 2026

FY 2025

Mar 10, 2026

Q4 2025

Mar 10, 2026

$0-100.0%

Q3 2025

Nov 10, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee